MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This clinical trial identifies and addresses barriers to pediatric medication adherence among families of children with acute lymphoblastic leukemia. Pediatric nonadherence (noncompliance) to medication is a significant public health problem, and rigorous research repeatedly documents that nonadherence increases risk for hospitalization, healthcare cost, disease progression, and death. Pediatric acute lymphoblastic leukemia (ALL) patients who miss 5% of 6-mercaptopurine (6-MP) doses within the 2-year 6-MP regimen have a 2.7-fold risk of cancer that comes back after a period of improvement (relapse). To address these families' needs, researchers have developed MedSupport, a theory-based multilevel intervention with targets at the organizational, healthcare team, and caregiver levels that is designed to address root barriers to medication adherence. This study is being done to better understand families' experiences giving their child oral chemotherapy at home and to help families cope with the day-to-day challenges of giving their child medication.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Rodzic dziecka z diagnozą białaczka limfoblastyczna (ALL)
- •Dziecko w wieku od 1 roku do poniżej 19 lat
- •Leczenie dziecka obejmuje lek merkaptopurynę (6-MP) podawany doustnie lub przez sondę
- •Biegła znajomość angielskiego lub hiszpańskiego
- •Rodzic ma dostęp do smartfona lub komputera z Internetem
- •Zgoda na udział w badaniu potwierdzona podpisanym dokumentem
✗ Disqualifies
- •Rodzic nie chce lub nie może przestrzegać wymogów badania
Simplified criteria — AI translation
Trial details
- Last updated (source)
- August 12, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Roswell Park Cancer Institute
Buffalo, United States
Trial contact
Kara M. Kelly
Kara M. Kelly
PRINCIPAL_INVESTIGATOR
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/13/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.